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Abstract: Cassia fistula stem bark was used for the preparation of aqueous extract and   synthesis 
of gold nanoparticles to evaluate the hypoglycemic effects of the plant. The synthesized gold 
nanoparticles were characterized by ultraviolet-visible spectroscopy for their absorbance   pattern, 
Fourier transform infrared spectroscopy to identify possible functional groups, and scanning 
electron microscopy to determine the size of the nanoparticles. The present investigation reports 
the efficacy of the gold nanoparticles as promising in the treatment of hyperglycemia. Body 
weight, serum glucose concentrations, liver function tests, kidney function tests, and lipid profile 
were analyzed. A significantly larger decrease in serum biochemistry parameters and an increase 
in body weight, total protein levels, and high-density lipoprotein were observed in rats with 
streptozotocin-induced diabetes treated with gold nanoparticles than in the ones treated with 
the aqueous extract. The results of this study confirm that C. fistula gold nanoparticles have 
promising antidiabetic properties.
Keywords: diabetes mellitus, Cassia fistula, aqueous, gold nanoparticles, biochemical 
analysis
Introduction
Diabetes mellitus is a chronic metabolic disorder1 characterized by loss of glucose 
homeostasis caused by defects in insulin secretion and action, resulting in impaired 
glucose metabolism.2 Epidemiological studies and clinical trials strongly support the 
notion of hyperglycemia as the main cause of coronary heart disease, cerebrovascular 
disease, renal failure, limb amputation, neurological complications, premature death, 
and lipid abnormalities in diabetics. Diabetes mellitus has reached epidemic proportions 
among the challenging unresolved health problems of the 21st century. The number of 
people suffering from the disease worldwide is increasing at an alarming rate, with a 
projected 366 million people likely to be diabetic by the year 2030 compared with the 
estimate of 191 million people in 2000.3 By convention, diabetes has been classified 
as type 1 (insulin-dependent) or type 2 (non-insulin-dependent). At present, control-
ling blood sugar levels by dietary modification, physical exercise, insulin therapy, 
and oral medications is advised.4 However, several hypoglycemic agents used for the 
treatment of diabetes are reported to have adverse effects, including liver problems, 
lactic acidosis, and diarrhea.5 Thus, use of these drugs may be limited depending 
on their pharmacokinetic properties, secondary failure rates, and side effects.6,7 The 
pathogenesis of diabetes mellitus and the possibility of its management with   existing 
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therapeutic agents without any side effects has been the 
subject of great interest in recent years.8
Researchers in the field of nanotechnology are gaining 
new insights into its versatile applications in the treat-
ment of various diseases, including diabetes mellitus. 
  Nanotechnology is an attractive area of research related 
to production of nanoparticles of variable size, shape, and 
chemical composition, with controlled dispersity, as well as 
their possible benefits in clinical medicine.9 The rapid devel-
opment of nanotechnology worldwide has been accompanied 
by massive generation and widespread use of engineered 
nanomaterials. Biosynthesis of nanoparticles, as a representa-
tive intersection of nanotechnology and biotechnology, has 
been the focus of increasing attention due to the growing need 
to develop environmentally friendly technologies for materi-
als synthesis.10 To date, nanoparticles have been extensively 
used in various applications, including drug discovery11 
and tissue engineering.12 Research into the preparation and 
biological applicability of noble metal nanoparticles with a 
nearly monodispersed size distribution and arbitrarily vari-
able size and geometry has attracted considerable research 
interest.13 Gold nanoparticles have a growing role in medical 
biotechnology.14 Production of nanoparticles can be achieved 
mainly through chemical, physical, and biological methods. 
Biological methods for nanoparticle synthesis using plants 
or plant extracts have been suggested as possible ecofriendly 
alternatives to chemical and physical methods.15
Since time immemorial, many medicinal plants have been 
used as dietary adjuncts and in the treatment of   numerous 
diseases without proper knowledge of their function. 
Although phytotherapy continues to be used in a number 
of countries, few plants have undergone scientific or medi-
cal scrutiny.16 Phytochemically mediated synthesis of gold 
nanoparticles marks a potential advance in the drug discovery 
era. A range of medicinal plants and plant extracts has been 
used for biological synthesis of gold nanoparticles. Singh 
et al17 reported a green biogenic approach for the synthesis of 
gold and silver nanoparticles using aqueous leaf extracts of 
Zingiber officinale, with nanoparticles formed in the average 
size range of 10 nm. Synthesis of gold nanoparticles from the 
extract of the Mirabilis jalapa flower18 showed formation of 
gold nanoparticles with a characteristic size of 100 nm and 
spherical in shape. Biomass of Stevia rebaudiana was used 
for synthesis of gold nanoparticles extracellularly, with nano-
particles in the size range of 8–20 nm.19 Huang et al evaluated 
the prospect of using sundried Cinnamom camphora leaf for 
the synthesis of nanosized noble metals of gold and silver 
under ambient conditions.20 Aqueous extracts of Withania 
coagulans,21 Cichorium endivia,22 Sesbania sesban (L),23 
Scoparia dulcis,24 and Trichosanthes dioica,25 as well as the 
combination of Cassia auriculata and Aegle   marmelos26 
were shown to have hypoglycemic and hypolipidemic effects 
in animals with experimentally induced diabetes. From the 
results of the different investigations mentioned above, it 
is evident that plants act as a natural reservoir for medici-
nal agents and avoid the common side effects of synthetic 
  chemicals. In this study, green synthesis of gold nanoparticles 
and aqueous extracts was done from the stem bark of one such 
potential plant, Cassia fistula (C. fistula), for investigation 
of its hypoglycemic activity.
C. fistula, a member of the Leguminosae family, has 
been extensively used in traditional Indian medicine. 
  Different parts of C. fistula are reported to have hepatopro-
tective, anti-inflammatory, antitussive, antifungal, antitu-
mor, antioxidant, and antibacterial activity.27 According to 
the different assays, the barks are known to have a higher 
antioxidant potential than other parts of the plant. The 
hypoglycemic and hypocholesterolemic effects of hexane 
extracts from C. fistula were studied by Nirmala et al,28 
who found a significant decrease in blood glucose levels 
and improvements in the lipid profile in comparison with 
the standard reference drug, insulin. These results suggest 
that the stem barks of hexane extracts from C. fistula pos-
sess strong antidiabetic activity.
C. fistula plant organs are known to be an important 
source of secondary metabolites. The stem bark of the plant 
acts as a reservoir for lupeol, β-sitosterol, and hexacosanol.29 
Rani and Kalidhar reported the presence of oxyanthraquinone 
and dihydroxyanthraquinone in the bark of the C. fistula 
plant.30 Stem bark of C. fistula has a high phenol, flavonoid, 
and proanthocyanidin phytochemical content.31 The present 
study investigated and compared the hypoglycemic effect 
of aqueous extract and gold nanoparticles synthesized from 
the stem bark of C. fistula in streptozotocin-induced diabetic 
rats, based on biochemical parameters.
Materials and methods
C. fistula belongs to the Leguminosae family. The bark of the 
C. fistula plant was obtained from a local market. The plant 
was taxonomically identified and a voucher specimen of the 
same plant (No HC-15) was authenticated and deposited in 
our department for future reference. The freshly collected 
barks were chopped, shade-dried, and coarsely powdered 
for further extraction.
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Preparation of C. fistula aqueous  
stem bark extract
We added 12 mL of double distilled water to a 250 mL 
beaker in a magnetic stirrer for 10 minutes, after which we 
added 60 mg of the weighed plant powder to the water under 
continuous stirring, and then boiled the mixture at 60°C 
for 15 minutes. The extract obtained was passed through a 
  Whatman filter and used for further experimental work.
Green synthesis of gold nanoparticles 
from C. fistula stem bark
The chemicals used for bioreduction of gold to gold nano-
particles (HAuCl4-chloroaurate) were purchased from 
  Sigma-Aldrich (St, Louis, MO). Preparation of the gold 
nanoparticles was done according to the method described 
by Katti et al31 with slight modifications. Finely coarse 
powder of C. fistula stem bark was used for phytochemical-
mediated synthesis of the gold nanoparticles, whereby 
60 mg of bark powder was added to 12 mL of double 
distilled water and continuously stirred; 50 mL of 1 mM 
aqueous HAuCl4 was subsequently added to the mixture 
whilst stirring. There was an immediate change in color 
from brown to ruby red, indicating formation of green gold 
nanoparticles. The extract was passed through a Whatman 
filter and the sample was characterized for the size and 
shape of the nanoparticles formed.
Characterization of phytochemically 
synthesized gold nanoparticles
Bioreduction of the gold nanoparticles was monitored using 
an ultraviolet-visible spectrophotometer. To deduce whether 
functional groups were present in the sample, Fourier trans-
form infrared (FTIR) spectroscopy was performed. Qualitative 
analysis was confirmed by scanning electron microscopy.
Ultraviolet visible spectroscopy analysis
Biological reduction of gold to gold nanoparticles was 
periodically monitored by the method described by Katti et al 
using a Lambda UV-650 spectrophotometer (Perkin Elmer, 
  Melville, NY). The ultraviolet-visible spectrophotometer read-
ings were recorded in the nanometer range of 190–900 nm. 
The samples were diluted with 2 mL of deionized water and 
absorbance values were recorded for the samples.
FTIR spectroscopy analysis
The synthesized gold nanoparticles were lyophilized and 
mixed with KBr pellets, and then subjected to a wide range 
of FTIR spectral analyses (Spectrum RX1, Perkin Elmer). 
Different peaks were obtained for the test samples.
Scanning electron microscopy  
of C. fistula gold nanoparticles
The synthesized green gold nanoparticles were characterized 
using scanning electron microscopy (300-N; Hitachi, Tokyo, 
Japan). A single drop of the sample was placed on the sample 
stage, and the aqueous solvent was allowed to evaporate for 
5 minutes. The dried sample was coated with gold using an 
ion sputter-coater with a gold target, and further analyzed 
for size and shape at different magnifications.
Experimental animals
Adult male albino Wistar rats weighing 150–200 g bred in 
the animal division of the King’s Institute, Chennai, were 
used in this study. The animals were acclimatized under 
appropriate light and dark conditions and fed a standard 
commercial pellet diet (Sai Enterprises, Chennai, India) and 
water ad libitum. The experimental protocol was approved 
by the institution’s animal ethics committee.
Chemical compounds
Streptozotocin was purchased from Sigma Aldrich for experi-
mental induction of diabetes. A freshly prepared solution of 
streptozotocin (60 mg/kg body weight [bw]) in 0.1 M citrate 
buffer (pH 4.5) was injected intraperitoneally. Seventy-two 
hours after injection of streptozotocin, rats with blood glucose 
levels in the range of 175–300 mg/dL were used for further 
treatment and analysis, while those rats with blood sugar 
levels outside the specified range were excluded. Insulin, the 
standard reference drug, was used for comparison of diabetic 
animals treated with the plant extract and those treated with 
the gold nanoparticles. Insulin 3 IU/kg bw/day was adminis-
tered to the rats with streptozotocin-induced diabetes.
Study design
Thirty-five rats (30 surviving diabetic rats and five normal 
rats) were used in this experiment. The rats were divided 
into seven groups, each containing five rats. Group 1 
comprised normal control rats given distilled water only; 
Group 2 comprised normal rats given aqueous extract of 
C. fistula (60 mg/kg bw) dissolved in 12 mL of double 
distilled water via an intragastric tube for 30 days; Group 3 
comprised normal rats given phytochemically synthesized 
gold nanoparticles containing C. fistula (60 mg/kg bw) 
continuously via gastric intubation for 30 days; Group 4 
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comprised diabetic controls given a single intraperitoneal 
injection of   streptozotocin (60 mg/kg), with only distilled 
water given throughout the experimental period; Group 5 
comprised   diabetic rats treated with the aqueous extract of 
C. fistula (60 mg/kg bw) dissolved in 12 mL of double dis-
tilled water, given daily via an intragastric tube for 30 days; 
Group 6 comprised diabetic rats treated with phytochemically 
synthesized gold nanoparticles of C. fistula (60 mg/kg bw) 
given continuously via gastric intubation for 30 days; and 
Group 7 comprised diabetic rats treated with insulin 3 IU/kg 
bw throughout the testing period.
The body weight of each animal was recorded before 
and after induction of diabetes, and after administration of 
the study treatment. Serum glucose level test was done to 
determine blood sugar levels. Blood samples were drawn 
from the tail vein during the course of the experiment. At 
the end of the experimental period (30 days), the rats were 
anesthetized with chloroform following a 12-hour fast. Blood 
samples were drawn by cardiac puncture into plain tubes. The 
blood samples were centrifuged at 3500 rpm for 20 minutes 
using a refrigerated centrifuge at 4°C (Remi Laboratory 
Instruments, Mumbai, India). The serum collected was stored 
at −20°C until needed.
Laboratory measurements
Serum glucose level test was done on the normal,   diabetic, and 
treated diabetic rats on days 1, 15, and 30 of the experimental 
period to determine blood glucose levels in the   animals. The 
blood samples collected were centrifuged at 3500 rpm for 
20 minutes and serum glucose levels were determined using 
the glucose oxidase-peroxidase method32 (Coral   Clinical 
Systems, Goa, India). Blood samples were examined to 
determine glycosylated hemoglobin (HbA1c) levels using the 
ion exchange resin method33 with kits purchased from Diotek 
India Ltd, Mumbai, India.
Assays for aspartate transaminase and alanine transami-
nase were done using the ultraviolet kinetic (International 
Federation of Clinical Chemistry) method34,35 with commercial 
kits (Autopak) obtained from Bayer Diagnostics Baroda, India. 
An alkaline phosphatase assay was also performed using the 
p-nitro phenyl phosphate method with Autopak diagnostic kits.
Serum albumin was determined using the bromcresol 
green method with an Autopak kit. The total protein pres-
ent in serum was estimated by the Biuret method36 using an 
Autopak kit. Globulin levels were calculated from total pro-
tein and albumin measurements. Serum urea,37 creatinine,38 
and uric acid39 levels were determined using diagnostic kits 
from Biosystems, Barcelona, Spain. Serum lipid profiles40 
were determined using reagent kits purchased from (Piramel 
Health care, Mumbai, India).
Statistical analysis
The statistical analysis was performed using SPSS software 
(v 17; SPSS Inc, Chicago, IL). The values were analyzed by 
one-way analysis of variance followed by Duncan’s multiple 
range test. The results are represented as the mean ± standard 
error of the mean for five rats. P values , 0.05 were consid-
ered to be statistically significant.
Results
The results of the ultraviolet-visible spectroscopic analysis of 
the aqueous extract and gold nanoparticles from the C. fistula 
plant are shown in Figure 1A and B. The characteristic 
absorbance peak for the aqueous plant extract was obtained 
at 236 nm whereas the absorbance peak observed for the gold 
nanoparticles was at 529 nm.
Figure 2A and B represents the FTIR spectral analysis 
for both the aqueous and gold nanoparticles. Characteristic 
functional groups responsible for formation of the particles 
in the samples were recorded.
Scanning electron microscopic images are shown in 
Figure 3. Figure 3A shows the gold nanoparticles formed as 
a result of reduction of gold ions. The image was taken at a 
magnification of 3000×. Figure 3B shows a closer view of the 
nanoparticles formed at a magnification of 8000×. Figure 3C 
shows the shape of the nanoparticles formed. Particles of 
different shapes were formed as a result of reduction of gold 
ions to gold nanoparticles by C. fistula (16,000×). Figure 3D 
shows the varying sizes of the nanoparticles, which were in 
the range of 55.2–98.4 nm (23,000×).
The body weights of the different groups of animals were 
in the range of 150–200 g (Figure 4). There was a reduction 
in body weight after induction of diabetes by streptozotocin. 
The mean body weight of the animals after 30 days of treat-
ment with aqueous extract, gold nanoparticles, and insulin 
was 151.60 ± 10.27 g, 178.80 ± 9.78 g, and 178.00 ± 2.00 g, 
respectively. The weight of the non-diabetic rats when treated 
with aqueous extract and with gold nanoparticles remained 
the same.
The serum glucose levels for the normal, diabetic, and 
treated diabetic animals are shown in Figure 5. The initial 
mean serum glucose levels for the seven groups of rats 
were in the range of 95–110 mg/dL. Fasting serum glu-
cose levels after administration of streptozotocin showed 
an increase in blood glucose levels. On treating the ani-
mals with the   aqueous extract or gold nanoparticles for 
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1192
Daisy and SaipriyaInternational Journal of Nanomedicine 2012:7
3.0
2.5
2.0
1.5
1.0
0.5
0.0
200 400 600 800 1000 1200
A
b
s
o
r
b
a
n
c
e
 
%
Wavelength cm−1
Figure 1A Ultraviolet-visible spectroscopic analysis of aqueous extract of the medicinal plant Cassia fistula.
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Figure 1B Ultraviolet-visible spectroscopic analysis of gold nanoparticles from the medicinal plant Cassia fistula.
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Figure 2A Characteristic Fourier transform infrared absorption spectra for aqueous extract of Cassia fistula.
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Figure 2B Characteristic Fourier transform infrared absorption spectra for Cassia fistula after bioreduction of gold ions to gold nanoparticles.
30 days, blood sugar levels were 211.05 ± 5.40 mg/dL and 
168.47 ± 16.18 mg/dL, respectively. Rats that also received 
insulin showed a decrease in blood sugar levels. In the dia-
betic control rats, blood sugar levels reached a peak by the 
end of the experimental period.
Mean HbA1c levels in normal rats were 6.49% ± 0.13% 
(Figure 6). There was a significant increase in total   hemoglobin 
in the diabetic control rats (13.59% ± 0.28%). After treatment 
with the aqueous extract or the gold nanoparticles, the animals 
showed a decrease in HbA1c levels to 11.45% ± 0.28% and 
10.40% ± 0.23%, respectively. The diabetic rats also treated 
with insulin showed a restoration in HbA1c levels. In rats 
treated with gold nanoparticles, HbA1c levels were found to 
be in the near normal range.
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Figure 3 Scanning electron microscopic images of phytochemically synthesized gold nanoparticles. (A) and (B) Formation of gold nanoparticles by reduction of gold ions. 
(C) Different shapes of particles formed (16,000×) and (D) nanometer size of gold nanoparticles (23,000×).
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A decrease in aspartate transaminase, alanine transami-
nase, and alkaline phosphatase levels and an increase in 
concentrations of albumin, globulin, and total protein were 
found in the diabetic rats treated with aqueous extract and 
gold nanoparticles, as shown in Figure 7. There was a signifi-
cant increase in serum albumin, globulin, and total protein 
content in the treated diabetic rats compared with the diabetic 
controls. The mean total protein content in rats treated with 
the aqueous extract was 5.60 ± 0.56 mg%, which was slightly 
lower than the total protein content in rats treated with the 
gold nanoparticles (6.41 ± 0.41 mg%).
There was a marked decrease in aspartate transaminase 
levels in the treated diabetic rats when compared with the 
diabetic control rats whose aspartate transaminase level was 
found to be 99.8 ± 1.68 mg%. Serum alanine transaminase 
levels are shown in Figure 7, and indicate a significant reduc-
tion in mean activity from 95.78 ± 0.83 to 84.34 ± 2.02 mg% 
in comparison with alanine transaminase levels in the 
untreated diabetic rats, which had a higher mean enzyme 
activity at 118.78 ± 1.49 mg%. The rats also treated with 
insulin had lower enzyme levels. The animals treated with 
gold nanoparticles showed a highly significant decrease in 
alanine transaminase to near normal levels, similar to that 
seen in the insulin-treated rats. Figure 7 shows that alka-
line phosphatase underwent a significant reduction to near 
normal levels in response to treatment with the aqueous 
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extract or gold nanoparticles of C. fistula after continuous 
administration for 30 days. The maximum decrease was 
observed in rats also receiving insulin, with the next largest 
decrease in alkaline phosphatase activity seen in the group 
treated with gold nanoparticles.
Serum urea, creatinine, and uric acid levels are shown in 
Figure 8, and were comparatively high in the diabetic control 
rats. On continuous treatment with C. fistula, there was a 
highly significant decrease in urea, creatinine, and uric acid 
levels in diabetic rats treated with the aqueous extract or gold 
nanoparticles, and a return to near normal levels.
Lipid profiles (total cholesterol, triglycerides, low-density 
lipoprotein, very low-density lipoprotein, and high-density 
lipoprotein) for the normal, treated nondiabetic rats, diabetic 
controls, and treated diabetic rats are shown in Figure 9. The 
serum lipid profile reached a peak in diabetic control rats, 
whereas the level of high-density lipoprotein decreased. 
After continuous treatment with the plant extract for 30 days, 
rats with streptozotocin-induced diabetes showed a marked 
decrease in cholesterol levels with a significant increase in 
high-density lipoprotein.
Discussion
The present work was carried out to compare the efficacy 
of phytochemically synthesized green gold nanoparticles 
with that of an aqueous extract of C. fistula as   hypoglycemic 
treatment for diabetes mellitus and its complications. 
  Biochemical parameters were assessed to support the pro-
posed hypothesis.
Diabetes mellitus is a common metabolic disease char-
acterized by increased circulating glucose concentrations. 
It is associated with a variety of microvascular, macrovas-
cular, neurological, and infectious complications, includ-
ing abnormal carbohydrate, fat, and protein metabolism. 
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Streptozotocin-induced diabetes is a well documented model 
of experimental diabetes, providing a relevant example of 
endogenous chronic oxidative stress due to hyperglycemia.41 
Streptozotocin is often used to induce diabetes mellitus in 
experimental animals because of its toxic effect on   pancreatic 
β cells.42,43 In the present study, a single intraperitoneal injec-
tion of streptozotocin 60 mg/kg bw was administered to the 
experimental animals resulting in toxicity to β cells, with 
emergence of clinical diabetes within 2–4 days.44
Nanotechnology can be defined as research on the 
design, synthesis, and structural manipulation of particles 
with dimensions smaller than 100 nm. Biosynthesis of gold 
nanoparticles with the help of medicinal plants has come 
into the limelight in nanobiotechnology due to the growing 
need to develop environmental friendly benign technologies. 
Plants are an excellent source of secondary metabolites, and 
have been found to be cost-effective and ecofriendly for 
the large-scale synthesis of nanoparticles.45 In this study, 
C. fistula was used for preparation of an aqueous extract and 
also for bioreduction of gold ions into gold nanoparticles. 
The reduction of chloroaurate ions to nanoparticles was more 
rapid upon addition of the plant biomass to the aqueous solu-
tion of HAuCl4. Au 3+, according to Padma and Bajpai,18 is 
a soft metal which binds to a biomass mainly via amino and 
sulfhydryl groups, which are considered to be soft ligands 
and carry more positive charge at low pH values, making 
them available for the binding and reduction of Au3+ to 
gold. Investigators have previously reported that formation 
of pure metallic nanoparticles and bimetallic nanoparticles 
by the reduction of metal ions is possibly facilitated by 
reducing sugars and/or terpenoids. In this study, reduction 
of chloroaurate ions could have occurred due to the presence 
of secondary metabolites, such as lupeol, β-sitosterol, and 
hexacosanol, in the stem bark of C. fistula.
Ultraviolet-visible spectroscopy is an indirect method for 
determining the reduction of gold ions to gold   nanoparticles. 
In certain metals, such as silver and gold, plasmon reso-
nance is responsible for their unique and remarkable optical 
  phenomena. Figure 1A and B show ultraviolet-visible spectra 
for aqueous extract and gold nanoparticles from C. fistula. 
The surface plasmon resonance band was obtained at 236 nm 
for the aqueous extract whereas the characteristic peak 
occurred at around 529 nm after 2 hours of reaction time for 
the phytochemically synthesized gold nanoparticles. Fierascu 
et al46 investigated the synthesis of gold nanoparticles from 
neem extract, which possessed a characteristic absorption 
peak at 525 nm. The bioreduction of gold ions occurred 
at much more rapid rate, and Shankar et al47 reported that 
the surface plasmon band arises from existence of free 
electrons in the conduction band due to the small particle 
size. The surface plasmon resonance peak in the ultraviolet 
absorption spectrum is shown by these plasmon resonant 
particles.48 To determine whether specific functional groups 
could be responsible for the bioreduction, FTIR spectra for 
the aqueous extract and gold nanoparticles were obtained. 
Figure 2A and B represent the FTIR spectral data for aque-
ous extract and gold nanoparticle samples from the stem 
bark of C. fistula. The vibrational spectrum for a   molecule 
of the aqueous extract is shown in Figure 2A. Several 
absorption peaks are centered around 3432.79, 2074.74, 
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1636.68, 1366.44, 1228.63, and 673.76 cm−1, which are 
attributable to the stretching vibrations of the O–H group 
at 3432.71 cm−1. Other characteristic stretching modes are 
found at 2074.74 cm−1 for N–H amines, 1636.68 cm−1 for 
C–C stretch (in the ring), 1366.44 cm−1 for the C–H bend, 
and C–O stretch mode at 1228.63 cm−1 and C–Br stretch 
at 673.76 cm−1. FTIR spectral data for the biosynthesized 
gold nanoparticles of C. fistula (Figure 2B) are attributable 
to the O–H group at 3430.49 cm−1. A C–H stretch exists 
in the region of 2850–3000 cm−1. Peaks at 1627.15 cm−1, 
1517.72 cm−1, and 1455.61 cm−1 can be assigned to N–H 
bending, N–O asymmetric stretching, and C–C stretching 
(in the ring). Stretching at 1248.11 cm−1 and 1113.35 cm−1 
contributes to the C–N stretching mode (aliphatic amines). 
Agnieszka et al49 reported a characteristic stretch at 3437 cm−1 
from a hydroxyl group through synthetic preparation of gold 
nanoparticles using the sodium citrate reduction method.50
Figure 3A–D represents the surface architecture of gold 
nanoparticles as a result of bioreduction of C. fistula, cap-
tured at different magnifications under a scanning electron 
microscope. At high resolution values, the nanoparticles were 
found to be polydispersed with rectangular and triangular 
shapes. The average size of the nanoparticles was in the range 
of 55.2–98.4 nm. Our scanning electron microscopy results 
are consistent with those of Elavazhagan and Arunachalam,51 
who reported formation of gold nanoparticles in the size 
range of 50–80 nm on reduction by Memecylon edule leaf 
biomass.
In our present study, biochemical parameters were 
unchanged in nondiabetic rats treated with the aqueous 
extract of C. fistula and gold nanoparticles synthesized from 
the same plant. There was a significant decrease in body 
weight in the animals with streptozotocin-induced diabetes. 
This finding is consistent with that of Shirwaikar et al52 who 
reported that diabetes mellitus is attributable to gluconeo-
genesis associated with a characteristic loss of body weight 
as a result of increased muscle wasting and loss of tissue 
proteins; this might also be attributable to dehydration and 
fat catabolism, as reported by Hakim et al.53 Oral administra-
tion of aqueous extract and biosynthetic gold nanoparticles 
achieved a remarkable improvement in body weight. There 
was a better body weight increment in animals treated with 
the gold nanoparticles than in those treated with the aqueous 
extract. The possible underlying mechanism for this gain in 
body weight is the effect of controlling muscle wasting, ie, 
reversal of antagonism.54
Serum glucose levels increased in rats with streptozotocin-
induced diabetes but not in nondiabetic rats.   Streptozotocin 
is used to induce diabetes mellitus via a selective cytotoxic 
effect on pancreatic β cells, triggering endogenous release 
of insulin and a consequent increase in blood glucose 
  levels.55 Our findings are in accordance with those of several 
other investigators in animals with streptozotocin-induced 
diabetes.
In the present study, animals with streptozotocin-induced 
diabetes showed marked reductions in blood glucose levels 
after 4 weeks of continuous administration of aqueous extract 
or gold nanoparticles. Possible underlying mechanisms by 
which the plant material controlled the increasing blood 
glucose levels are potentiation of pancreatic secretion of 
insulin from β cells in the islets of Langerhans56 and increased 
transport of blood glucose to peripheral tissues.57 Our results 
are in accordance with those of Nirmala et al,28 who reported 
an increase in insulin secretion and decreased blood glucose 
levels in animals with streptozotocin-induced diabetes treated 
with hexane extracts of stem bark from C. fistula.
The glucose-lowering effect of the experimental treat-
ments was compared with that of insulin. Insulin was found 
to be more effective than the aqueous extract and gold 
nanoparticles in reducing blood glucose levels. The gold 
nanoparticles were the most effective after insulin in lowering 
blood glucose levels. Our findings are consistent with those 
of Bharathmanikanth et al,58 who treated diabetic rats with 
gold nanoparticles at a dose of 2.5 mg/kg.
In controlled or poorly controlled diabetes, there is 
increased glycosylation of a number of proteins, including 
hemoglobin.59 Increased serum HbA1c levels in rats with 
streptozotocin-induced diabetes suggest an increased rate 
of alkylation and free radical formation. In this study, there 
was a significant decrease in HbA1c levels down to the near 
normal range in diabetic animals treated with the C. fistula 
aqueous extract or gold nanoparticles. Our HbA1c data cor-
roborate those of Oluba et al,60 who reported that Ganoderma 
lucidum extracts achieve a significant reduction in HbA1c, 
which could have possibly occurred as a result of antioxidant 
activity in the plants. Oral administration of the aqueous 
extract and gold nanoparticles had an effect on HbA1c, by 
preventing its elevation. C. fistula may also possess anti-
oxidant activity, which would have scavenged free radicals, 
leading to a significant decrease in HbA1c in diabetic rats. 
Gold nanoparticles derived from C. fistula were found to be 
effective in restoring HbA1c to normal levels, probably as a 
result of efficient scavenging activity.
The increased transaminase levels indicate hepatic dys-
function in animals with streptozotocin-induced diabetes. 
Aspartate transaminase and alanine transaminase are released 
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when injury involves organelles such as the   mitochondria.61 
Transaminases mediate the catalysis of amino transfer 
reactions, and are vital markers of liver injury in clinical 
diagnostics.62 Alkaline phosphatase is a hydrolase enzyme 
located in the cytoplasm,63 and is responsible for removing 
phosphate from nucleotides and proteins released due to 
hepatic cellular damage. Assessment of marker enzyme 
(aspartate transaminase, alanine transaminase, and alkaline 
phosphatase) levels in streptozotocin-induced diabetic rats 
showed an elevation resulting from leakage of enzymes into 
the bloodstream.64 In the present investigation, there was a 
progressive increment in aspartate transaminase, alanine 
transaminase, and alkaline phosphatase levels in the diabetic 
rats. Gold nanoparticles are believed to play a protective role 
in the decrease of transaminase levels. Our results are in 
line with those of Patrick et al65 and   Mahmoud et al,66 who 
reported an inhibitory effect of different plant extracts on 
transaminase activity.
Serum albumin and globulin levels were markedly 
decreased in the diabetic control group. Total protein levels 
are significantly decreased in rats with streptozotocin-induced 
diabetes due to increased protein catabolism.67 The present 
study found that daily administration of an aqueous extract 
or gold nanoparticle sample from C. fistula to diabetic rats 
gradually increased their protein levels, and that the gold 
nanoparticles had a pronounced effect on protein content, 
with results for total protein being in accordance with those 
of Akah et al68 who reported that fraction 6 of Vernonia 
amygdalina leaf extracts was capable of normalizing total 
protein and albumin levels in rats with streptozotocin-induced 
diabetes.
Diabetes affects both glucose and lipid metabolism.69 The 
abnormally high concentration of serum lipids in diabetes 
is mainly due to an increase in mobilization of free fatty 
acids from peripheral fat depots.70 The present investigation 
shows an increase in serum lipoproteins (total cholesterol, 
triglycerides, low-density lipoprotein, very low-density lipo-
protein). Such an increase in lipid content increases the risk 
of coronary heart disease and atherosclerosis.
Treatment of animals with streptozotocin-induced dia-
betes with gold nanoparticles from C. fistula and also with 
its aqueous extract returned lipid levels back to near normal. 
This improvement may be attributable to the cardioprotective 
properties of β sitosterol, a plant sterol present in the stem 
bark of C. fistula. Our data on the lipid profile run parallel 
with the results of Nirmala et al28 who reported an improved 
lipid profile in rats with streptozotocin-induced diabetes 
treated with hexane extracts from C. fistula stem bark.   
The lipid-lowering effects of gold nanoparticles were found 
to be more effective than those of the aqueous extract. 
High-density lipoprotein levels were significantly increased, 
indicating a reversed atherogenic risk which might be due 
to increased activity of lecithin cholesterol acyltransferase, 
which in turn contributes to regulation of serum lipids.71
Diabetic hyperglycemia produces elevation of plasma levels 
of urea and creatinine which are considered to be significant 
markers of renal dysfunction.72 Urea, creatinine, and uric 
acid levels were elevated in diabetic rats during the present 
experiment, indicating impaired renal function. On admin-
istering gold nanoparticles and aqueous extracts for 30 days, 
serum urea, creatinine and uric acid levels steadily returned 
to near   normal. These results are in agreement with those of 
Daisy et al73 who reported that renal markers in serum were 
decreased on administration of crude hexane extracts from 
Costus speciosus to animals with streptozotocin-induced 
diabetes.   Administering gold nanoparticles orally to diabetic 
rats decreased serum urea, creatinine, and uric acid more 
effectively, and could be explained by the regenerative ability 
of the renal tubules.74
Conclusion
Reduction of gold ions by C. fistula stem bark resulted in the 
formation of stable nanoparticles with different   morphologies. 
Use of gold nanoparticles synthesized from C. fistula stem 
bark for the treatment of rats with streptozotocin-induced dia-
betes reduced serum blood glucose concentrations, induced 
favorable changes in body weight, improved transaminase 
activity, achieved a better lipid profile, and reversed renal 
dysfunction to a greater extent that did aqueous extracts from 
the same plant. This study indicates that phytochemically 
synthesized gold nanoparticles are better hypoglycemic 
agents in the treatment of diabetes mellitus and its associ-
ated complications.
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